Goodwin advised Borderless on the fundraising. Borderless announced its £2.5 million seed financing. The round was led by Backed VC and involved Tiny VC. The company...
You must be a Standard 1 Year member to access this content.
Goodwin advised Creandum on its investment. Lindus Health announced its $18 million Series A round led by Creandum. Other investors included Peter Thiel and returning investors Seedcamp,...
You must be a Standard 1 Year member to access this content.
Goodwin advised Rapport Therapeutics on the fundraising. Rapport Therapeutics announced the completion of its $150 million in Series B funding. Led by Cormorant Asset Management, the...
You must be a Standard 1 Year member to access this content.
Goodwin advised Dynatrace on the deal. Dynatrace (NYSE: DT) announced it has signed a definitive agreement to acquire Rookout. The addition of Rookout to the Dynatrace®...
You must be a Standard 1 Year member to access this content.
Goodwin Procter acted as legal counsel to ReWalk, and Wilson Sonsini acted as legal counsel to AlterG. ReWalk Robotics Ltd. (Nasdaq: RWLK) announced closing of the...
You must be a Standard 1 Year member to access this content.
Goodwin advised Astex on the agreement. Astex Pharmaceuticals (UK) announced its exclusive worldwide research collaboration and license agreement with MSD to identify small molecule candidates with...
You must be a Standard 1 Year member to access this content.
Goodwin advised The Brydon Group on its investment. Renesan and Visonex announced a strategic combination of their businesses that will offer customers a flexible and secure...
You must be a Standard 1 Year member to access this content.
Goodwin and Gleiss Lutz advised Slate Asset Management on the deal, while White & Case and Fieldfisher advised x+bricks. Slate Asset Management entered into an agreement...
You must be a Standard 1 Year member to access this content.
Goodwin advised bit.bio on the agreement. BlueRock Therapeutics LP, a wholly owned, independently operated subsidiary of Bayer AG, and bit.bio announced a collaboration and option agreement for...
You must be a Standard 1 Year member to access this content.
Goodwin is advising the Official Committee of Unsecured Creditors on the procedure. Novan, Inc. (Nasdaq: NOVN) and its wholly owned subsidiary, EPI Health, LLC, announced that it...
You must be a Standard 1 Year member to access this content.
Goodwin advised InTandem on the deal, and Koley Jessen served as legal counsel for OrthoNebraska. InTandem Capital Partners, LLC announced that it has completed a strategic equity...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
